Between Feb 12 and July 30 , 2010 , 173 patients at 43 investigational sites in 12 countries were enrolled into the study , of whom 162 were eligible and were randomly assigned to the two treatment groups ( 81 to the olaparib plus chemotherapy group and 81 to the chemotherapy alone group ) .